Version for the Visually Impaired
Language
English
Қазақша
Русский
Search
Site Search
About the Holding
General Information
Management
Sole Shareholder
Executive Body of the Holding
Board of Directors
Holding Structure
Corporate Governance
External and Internal Auditor
Risk Management
Human Resources Policy
Corporate Secretary
Corporate Documents
Rules
Corporate Events
Regulatory Legal Acts
Reports
Subsidiaries
Cooperation
Partnership
Scientific and Technological Council
Council on Biological Safety
Compliance and Anti-Corruption
Schedule of Personal Reception of Citizens
FAQ
Science
Our Scientists
Research Laboratories
Scientific Activity
Services
Biological Safety
Developments in the Field of Biological Safety
System for Forecasting and Monitoring Particularly Dangerous Infections
Laboratories in the Field of Biological Safety
Commercialization and Production
Commercialization Office
Procurement Plan
High-Tech Products
Production Sites
Testing Laboratories
Qualification Assessment Provider
Certificates, Licenses and Accreditation Certificates
Procurement
Procurement Rules
Procurement Plan
Press Center
Press Release
News
Interview
Career
Vacancies
Contacts
Conference
Collection of Abstracts
News
Introduction of breakthrough technology for the treatment of blood cancer into practical health care
15.02.2023
85
About the meeting with representatives of F. Hoffmann-La Roche LTD in Kazakhstan
31.01.2023
82
On the workshop on the creation of an interdepartmental science cluster
12.12.2022
79
On Establishment of Joint Stock Company “National Holding “QazBioPharm”
27.08.2022
79
Kunsulu Zakarya Appointed Head of QazBioPharm Holding
22.08.2022
75
«QazBioPharm» biopharmaceutical holding company established
21.07.2022
73
New National Holding to Address Biosecurity Issues
18.07.2022
86
7
8
9
10
11
